Management Team

Patrik Dahlen, Chief Executive Officer

Patrik holds a MSc in Biochemistry from Åbo Akademi University and a PhD in Biochemistry from Turku University. He brings over 30 years of senior level experience as an executive in the life science and diagnostics industry. Patrik contributes with broad international experience in Europe and the US with substantial diagnostic and international industry expertise. As Chief Executive Officer of Dako, Patrik, carried out a major strategic repositioning of the company as a leading supplier of cancer diagnostics. As President of Life Sciences at the American company Perkin Elmer, Patrik was instrumental in building the company’s diagnostic business with a niche focus on diagnostic systems for neonatal and prenatal screening. He has led organizations ranging from 10 to 2000 people based in Finland, Denmark, UK and USA and has considerable public company experience. Additional experience includes CEO, SSI Diagnostic, Denmark, CEO, Immunodiagnostic Systems (IDS), UK; CEO NeuroSearch, Denmark.

Current appointments: Chairman of the Board of Visiopharm and Advalight. Board member of SSI Diagnostica.

Completed appointments (last five years): Board Member of LEO Pharma and Immunovia AB.

Rolf Ehrnström, Chief Scientific Officer

Rolf holds a MSc in biochemistry & biotechnology engineering from Royal Institute of Technology, Stockholm, Sweden. Rolf is the owner of Reomics AB and an independent partner at Ventac Partners. He has long experience of leading research and has been a Corporate Vice President R&D and Chief Scientific Officer at Dako/Agilent and Gyros AB. Rolf has also experience as a Science Director at Amersham Pharmacia Biotech.

Current appointments: Board Member of Reomics AB sand Fluimedix A/S Danmark. Member of the Nomination Committee of Idogen AB.

Completed appointments (last five years): Board Member of Biomonitor A/S.

Hans Liljenborg, Chief Financial Officer

Hans Liljenborg has a degree as subject teacher in Business Administration and Mathematics from Lund University, Sweden. Hans has long experience as Financial Manager for growing, global medical technology companies and has been Finance Director at Physio Control Inc, Jolife AB and Finance Manager at Vivoline Medical AB, listed on Nasdaq First North in March 2015. He also operates an own accounting firm.

Current appointments: Board Member of ADAYS AB. Deputy Director of Entreprenörskompetens i Lund AB, Gantus Training AB and IES Interactive Executive Search AB. Auditor at Personalkooperativet Byns Förskola Ekonomisk förening. Holder of Prosperus.

Completed appointments (last five years): Leading positions at E-vård Sverige AB, Jolife AB, Quick-Cool AB and Vivoline Medical AB. Auditor at Bostadsrättsföreningen Långgårdsgatan 17 and Solbacka Trading.

Laura Chirica, Chief Commercial Officer

Laura holds a PhD in Biochemistry from Umeå University, Sweden, a MSc in Biochemistry and a BSc in Biotechnology. With more than 15 years experiences in leading commercial positions within the life science and diagnostics industry, Laura contributes with an extensive experience in business, organization and strategic development, sales, strategic and tactical marketing, product management and product support. She has a track record of leading and restructuring international sales and marketing organizations, driving business development, champion integration of acquired companies as well as developing branding and market communication platforms. Much of her experience comes from leadership in multinational management teams and organizations in Scandinavia, Europe, USA and Asia. Previous positions include VP Sales and Marketing Euro Diagnostica AB, Director Purification Technologies Europe Sartorius Stedim, Global Marketing Director Dako A/S, and Global Marketing Program Manager GE Healthcare.

Current appointments: Board Member of SenzaGen AB.

Completed appointments (last five years): Leading position at Euro-Diagnostica AB.

Michael Pettigrew, Senior VP Sales North America

Michael has a Bachelor of Science in biology at Fairleigh Dickinson University. He brings over 30 years of experience and has focused his extensive global expertise in the mana­gement of marketing & sales, business and strategic account development, licensing, mergers & acquisition, and commercial technology platform development. While he was at Thermo Fisher Scientific, he managed large regional based sales teams (USA, Canada, Latin America, and South America) by providing sales, technical support, and customer support. Prior to Thermo Fisher Scientific, Michael was the Vice President of Corporate Developme­nt at Magellan Biosciences, where he was focused on M&A and licensing. Prior to that, Michael held positions at GE Healthcare (Vice President, Sales), Amersham (Vice President, Genomics), and Pharmacia (Director of Marketing, North America).

Current appointments: None.

Previous appointments (past five years): VP Sales Americas Thermo Fisher Scientific.

Hans Christian Pedersen, VP of Strategy & Business Development

Hans Christian holds a MSc in Molecular biology from University of Copenhagen, Denmark. He brings over 18 years of industry experience working with drug development, antibody development, breast cancer research, companion diagnostics development, IVD global marketing, scientific affairs and business development. Hans Christian has an extensive experience in both development and commercialization of diagnostic tests and has been involved in building and launching strategic partnerships with global pharma partners.

Current appointments: None

Completed appointments (last five years): Business Development Director, Unilabs; Director of Scientific Affairs, Agilent Technologies and Head of Companion Diagnostics and IHC reagents, Agilent Technologies.

Linda Mellby, VP Research & Development

Linda received her PhD in Immunotechnology from Dept. of Immunotechnology within CREATE Health Translational Cancer Center, Lund University, in 2010, and a MSc in Chemistry Engineering in 2004. Linda has more than 15 year’s experiences of recombinant antibody microarray technology, the Immunovia platform. She has deep knowledge about platform features, technology development as well as clinical applications within oncoproteomics and autoimmunity. She has been one of the key researchers managing the development of the Immunovia antibody microarray platform for disease proteomics, conducting extensive work related to process optimizations, standardizations as well as clinical studies.

Current appointments: None

Completed appointments (last five years): None

Lotta Blomgren, Operations Director

Lotta holds a MSc in Chemical Engineering from Lund University, Sweden. Lotta has more than 30 years’ experience within the life science and diagnostics industry, whereof 15 years in leading positions. She contributes with extensive experience from leading manufacturing, quality control and logistics teams, as well as managing transfer of new products from development to commercial scale. Her track record includes strategic reorganizations of international manufacturing networks, managing people and project portfolios, as well as due diligence of potential acquirement of new companies and Contract Manufacturing (CMO).
Previous positions include VP Technical Operations at Euro Diagnostica AB, Head of Supply Chain Bioglan AB, Director Product & Technology Support Ferring A/S, Head of Process Development Ferring AB, cross functional roles within Process Development and Project Management at Astra AB, Kabi Pharmacia AB and ACO AB.

Current appointments: None

Completed appointments (last five years): Leading positions at Bioglan AB and EuroDiagnostica AB.

Annika Andersson, QA/RA Director

Annika is a Biomedical Scientist from Malmö University. She has more than 25 years’ experience within the life science and diagnostics industry, with the main focus on regulatory affairs and quality assurance of in vitro diagnostic medical devices. Annika contributes with global experience within regulatory strategies and regulatory submissions of IVDs. Her track record includes leading successful regulatory approval processes of medical devices for IVD CE marking as well as IVD approvals in Canada, China, India, Japan, Korea, Mexico, Russia and 510(k) clearances in USA.

Current appointments: None

Previous appointments (past five years): Leading position at Euro Diagnostica AB (now SVAR Life Science AB).


Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports